awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34737478-52156A62-05CF-4FFE-9112-5FA0F1B7F9FD
Q34737478-52156A62-05CF-4FFE-9112-5FA0F1B7F9FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34737478-52156A62-05CF-4FFE-9112-5FA0F1B7F9FD
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
P2860
Q34737478-52156A62-05CF-4FFE-9112-5FA0F1B7F9FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34737478-52156A62-05CF-4FFE-9112-5FA0F1B7F9FD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ca5821fd8d1d8b11fa734c13ec367922d727b150
P2860
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial